The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 339:848-849 September 17, 1998 Number 12
NextNext

Progressive Multifocal Leukoencephalopathy, HIV, and Highly Active Antiretroviral Therapy

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
-Related Article
 by Hall, C. D.
-PubMed Citation
To the Editor: The results of AIDS Clinical Trials Group Study 243, reported by Hall et al. (May 7 issue),1 show that neither cytarabine nor regimens of one or two reverse-transcriptase inhibitors affect the course of progressive multifocal leukoencephalopathy in patients infected with the human immunodeficiency virus (HIV). Recent case reports have indicated that neurologic conditions and survival may improve in patients with progressive multifocal leukoencephalopathy who receive highly active antiretroviral therapy, including protease inhibitors.2,3,4 Protease inhibitors became widely available only after the cytarabine trial.1

We evaluated survival and the presence or absence of JC virus DNA in cerebrospinal fluid . . . [Full Text of this Article]

References


Related Letters:

Central Nervous System Depression after Ingestion of RenewTrient
Olson K. R., Dyer J. E., Haller C., Nelson L. S., Howland M. A., Hoffman R. S.
Extract | Full Text  
N Engl J Med 1999; 340:570, Feb 18, 1999. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.